Search

NeuroDiscovery completes Phase 1 of drug trials

Perth-based neurology research company NeuroDiscovery Ltd will seek approval from the British Medicines and Healthcare products Regulatory Agency to extend trials of neuropathic pain treatment NSL-043 to higher doses, after the first phase of trials was completed.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Transactions

04/04/13
$25k Bought
07/02/13
$30k Bought
05/07/12
$1k Bought
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer